Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real‐life study
Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real‐life study is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real‐life study have?
Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real‐life study has 97 citations in the OpenAlex counts ScholarIQ stores.
When was Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real‐life study published?
Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real‐life study has 2020 year in the ScholarIQ index.
What is the open-access status of Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real‐life study?
Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real‐life study has bronze oa status in the ScholarIQ index.
What is the DOI of Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real‐life study?
The DOI for Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real‐life study is on the source record.
What is the PMID of Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real‐life study?
The PMID for Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real‐life study is on the source record.
What is the OpenAlex record for Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real‐life study?
The OpenAlex for Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real‐life study is on the source record.